Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
long intergenic non-protein coding RNA 1412 | 0.931 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 1221 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2018 | |||||||||
|
CCDC26 long non-coding RNA | 0.647 | 0.615 |
|
phenotype | 0.100 | None | 1.000 | 2 | 4 | 2016 | 2018 | |||||||||
|
JAZF1 antisense RNA 1 | 1.000 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
CADM3 antisense RNA 1 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2016 | 2016 | |||||||||
|
smooth muscle and endothelial cell enriched migration/differentiation-associated lncRNA | 0.931 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene 5 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||||
|
HLX antisense RNA 1 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
CRTC3 antisense RNA 1 | 0.792 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 1478 | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
ZFPM2 antisense RNA 1 | 0.736 | 0.385 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
LMNB1 divergent transcript |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||||
|
RERE antisense RNA 1 | 0.890 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 2652 | 1.000 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
NCF4 antisense RNA 1 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
HLA complex P5 | 0.595 | 0.808 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
coiled-coil domain containing 162, pseudogene | 0.890 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | |||||||||
|
fucosyltransferase 6 | 0.695 | 0.385 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
chromosome 20 open reading frame 203 | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 299 | 0.743 | 0.346 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | |||||||||
|
cancer susceptibility 15 | 0.603 | 0.577 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
MIR4435-2 host gene | 0.604 | 0.692 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | |||||||||
|
MIR3936 host gene | 0.861 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
Pvt1 oncogene | 0.495 | 0.731 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 |